Business
"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on the Subsidiary's Rivaroxaban Tablets Obtaining Supplementary Approval for Additional Specifications and Other Matters
"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on the Subsidiary's Rivaroxaban Tablets Obtaining Supplementary Approval for Additional Specifications and Other Matters
About this update from Zhejiang Conba Pharmaceutical Co., Ltd. Class A
Announcement on the Subsidiary's Rivaroxaban Tablets Obtaining Supplementary Approval for Additional Specifications and Other MattersThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:View Attachment
View stock analysis, news, and events for Zhejiang Conba Pharmaceutical Co., Ltd. Class A